Effects on turning of microinjections into basal ganglia of D1 and D2 dopamine receptors agonists and the cannabinoid CB1 antagonist SR141716A in a rat Parkinson's model-Reference-Cited by-同舟云学术

Effects on turning of microinjections into basal ganglia of D1 and D2 dopamine receptors agonists and the cannabinoid CB1 antagonist SR141716A in a rat Parkinson's model

Published:2004-07 Issue:2 Volume:16 Page:377-385
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

El Banoua Fadwa,Caraballo Isabel,Flores Juan A,Galan-Rodriguez Beatriz,Fernandez-Espejo Emilio

Publisher

Elsevier BV

Subject

Neurology

Reference56 articles.

1. The functional anatomy of basal ganglia disorders;Albin;Trends Neurosci.,1989

2. Blockade of cannabinoid receptors by SR141716A selectively increases FOS expression in rat mesocorticolimbic areas via reduced dopamine D2 function;Alonso;Neuroscience,1999

3. Endocannabinoids control spasticity and tremor in a multiple sclerosis model;Baker;Nature,2000

4. Reversal of dopamine D2 receptor responses by an anandamide transport inhibitor;Beltramo;J. Neurosci.,2000

5. Influence of cannabinoids on electrically evoked dopamine release and cAMP generation in the rat striatum;Cadogan;J. Neurochem.,1997

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The current role of cannabis and cannabinoids in health: A comprehensive review of their therapeutic potential;Life Sciences;2023-09

2. Therapeutic uses of Cannabis sativa L. Current state and future perspectives;Current Applications, Approaches, and Potential Perspectives for Hemp;2023

3. Probable role of the hyperpolarization-activated current in the dual effects of CB1R antagonism on behaviors in a Parkinsonism mouse model;Brain Research Bulletin;2022-12

4. Time-Course of Alterations in the Endocannabinoid System after Viral-Mediated Overexpression of α-Synuclein in the Rat Brain;Molecules;2022-01-14

5. Parkinson’s disease related alterations in cannabinoid transmission;Brain Research Bulletin;2022-01